Resistin is associated with biomarkers of inflammation while total and high-molecular weight adiponectin are associated with biomarkers of inflammation, insulin resistance, and endothelial function
- PMID: 19920090
- PMCID: PMC2828059
- DOI: 10.1530/EJE-09-0555
Resistin is associated with biomarkers of inflammation while total and high-molecular weight adiponectin are associated with biomarkers of inflammation, insulin resistance, and endothelial function
Erratum in
- Eur J Endocrinol. 2010 Aug;163(2):359
Abstract
Objective: Adiponectin and resistin have been linked to inflammation, endothelial dysfunction, and/or insulin secretion or resistance. It remains to be elucidated which of these adipokines is associated primarily with biomarkers of all or only some of these categories, i.e. biomarkers of inflammation, endothelial dysfunction, and/or insulin secretion or insulinemia.
Design and methods: We studied 1065 healthy women, Nurses' Health Study participants, who provided blood samples in 1989-1990. A cross-sectional analysis was conducted to assess the relationships between total and high-molecular weight (HMW) adiponectin and resistin with inflammatory markers and biomarkers of endothelial dysfunction, insulin secretion, and insulinemia.
Results: Resistin was positively associated with the inflammatory markers soluble tumour necrosis factor-alpha receptor II and interleukin-6 but not with any biomarkers of endothelial function, glycemia, insulinemia, or markers of insulin secretion after multivariate adjustment for age and body mass index (BMI). In both crude and multivariate analyses, total adiponectin was inversely associated with insulin, proinsulin, C-peptide, HbA1c, sE-selectin, and C-reactive protein (CRP) levels. HMW adiponectin was inversely associated with circulating insulin, proinsulin, C-peptide, HbA1c, sE-selectin, and CRP concentrations, even after adjustment for age, BMI, lifestyle factors, exercise, the use of medications as well as the other biomarkers of interest. Total and HMW adiponectin demonstrated negative associations with soluble intercellular adhesion molecule-1, which became nonsignificant after adjustment for confounders, whereas positive associations between soluble vascular cell adhesion molecule-1 and total adiponectin became significant only after multivariate adjustment.
Conclusions: Total and HMW adiponectin are inversely associated with markers of insulin secretion/insulinemia, endothelial function, and inflammation. Resistin is positively associated only with markers of inflammation.
Similar articles
-
Adherence to healthy eating patterns is associated with higher circulating total and high-molecular-weight adiponectin and lower resistin concentrations in women from the Nurses' Health Study.Am J Clin Nutr. 2008 Nov;88(5):1213-24. doi: 10.3945/ajcn.2008.26480. Am J Clin Nutr. 2008. PMID: 18996855 Free PMC article.
-
Increased levels of tumour necrosis factor-alpha (TNF-alpha) in patients with Type II diabetes mellitus after myocardial infarction are related to endothelial dysfunction.Clin Sci (Lond). 2006 Jun;110(6):673-81. doi: 10.1042/CS20050353. Clin Sci (Lond). 2006. PMID: 16466346
-
Independent associations of total and high molecular weight adiponectin with cardiometabolic risk and surrogate markers of enhanced early atherogenesis in black and white patients with rheumatoid arthritis: a cross-sectional study.Arthritis Res Ther. 2013 Sep 20;15(5):R128. doi: 10.1186/ar4308. Arthritis Res Ther. 2013. PMID: 24286214 Free PMC article.
-
Novel adipokines, high molecular weight adiponectin and resistin, are associated with outcomes following lower extremity revascularization with autogenous vein.J Vasc Surg. 2010 May;51(5):1152-9. doi: 10.1016/j.jvs.2009.12.051. Epub 2010 Mar 11. J Vasc Surg. 2010. PMID: 20223619 Free PMC article.
-
Inflammatory cytokines and metabolic risk factors during growth and maturation: influence of physical activity.Med Sport Sci. 2010;55:43-55. doi: 10.1159/000321971. Epub 2010 Oct 14. Med Sport Sci. 2010. PMID: 20956859 Review.
Cited by
-
Changes in adipose tissue macrophages and T cells during aging.Crit Rev Immunol. 2014;34(1):1-14. doi: 10.1615/critrevimmunol.2013006833. Crit Rev Immunol. 2014. PMID: 24579699 Free PMC article. Review.
-
Resistin in rodents and humans.Diabetes Metab J. 2013 Dec;37(6):404-14. doi: 10.4093/dmj.2013.37.6.404. Diabetes Metab J. 2013. PMID: 24404511 Free PMC article.
-
Serum adiponectin in relation to race-ethnicity and vascular risk factors in the Northern Manhattan Study.Metab Syndr Relat Disord. 2013 Feb;11(1):46-55. doi: 10.1089/met.2012.0065. Epub 2012 Nov 5. Metab Syndr Relat Disord. 2013. PMID: 23127161 Free PMC article.
-
Serum resistin: A possible link between inflammation, hypertension and coronary artery disease.Pak J Med Sci. 2019;35(3):641-646. doi: 10.12669/pjms.35.3.274. Pak J Med Sci. 2019. PMID: 31258568 Free PMC article.
-
The association of plasma resistin with dietary sodium manipulation, the renin-angiotensin-aldosterone system, and 25-hydroxyvitamin D3 in human hypertension.Clin Endocrinol (Oxf). 2011 Mar;74(3):294-9. doi: 10.1111/j.1365-2265.2010.03922.x. Clin Endocrinol (Oxf). 2011. PMID: 21050256 Free PMC article.
References
-
- Chan J, Mantzoros C. Role of leptin in energy-deprivation states: normal human physiology and clinical implications for hypothalamic amenorrhea and anorexia nervosa. Lancet. 2005;366:74–85. - PubMed
-
- Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev. 2005;26:439–451. - PubMed
-
- Stefan N, Stumvoll M. Adiponectin--its role in metabolism and beyond. Horm Metab Res. 2002;34:469–474. - PubMed
-
- Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 2002;8:1288–1295. - PubMed
-
- Spranger J, Kroke A, Mohlig M, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF. Adiponectin and protection against type 2 diabetes mellitus. Lancet. 2003;361:226–228. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- HL34594/HL/NHLBI NIH HHS/United States
- R01 DK058785/DK/NIDDK NIH HHS/United States
- R56 DK058785/DK/NIDDK NIH HHS/United States
- R01 DK081923/DK/NIDDK NIH HHS/United States
- HL60712/HL/NHLBI NIH HHS/United States
- DK58845/DK/NIDDK NIH HHS/United States
- R01 HL065582/HL/NHLBI NIH HHS/United States
- HL65582/HL/NHLBI NIH HHS/United States
- R01 DK079929/DK/NIDDK NIH HHS/United States
- R01 HL034594/HL/NHLBI NIH HHS/United States
- DK081913/DK/NIDDK NIH HHS/United States
- R01 HL060712/HL/NHLBI NIH HHS/United States
- P30 DK040561/DK/NIDDK NIH HHS/United States
- R01 DK058845/DK/NIDDK NIH HHS/United States
- DK58785/DK/NIDDK NIH HHS/United States
- DK79929/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous